BioSpace News Archive

Job Trends

Treating a Rare Genetic Disorder That Causes Colon Cancer in Children

UH Pharmaceutical Scientist Eyeing New Drug that Recycles Through the Colon

November 28, 2018
·
3 min read
Environmental exposures early in life modify immune responses – effects visible even in adolescence

The prevalence of allergic diseases has increased significantly over the last decades, creating substantial financial and societal burdens. Due to this, researchers are trying to discover new approaches to the prevention and treatment of these diseases.

November 28, 2018
·
4 min read
EU supports F2G Biotech in Austria with EUR 24 million for antifungal research and innovation

EIB financing strengthens F2G´s research and innovation

November 28, 2018
·
4 min read
Deals

Galapagos increases share capital through warrant exercises on November 23, 2018

Galapagos NV announces a share capital increase arising from warrant exercises.

November 28, 2018
·
2 min read
Policy

MorphoSys Announces Approval of Tremfya(R) (Guselkumab) in Japan for the Treatment of Patients with Palmoplantar Pustulosis

MorphoSys AG announced today that its licensee’s affiliate, Janssen Pharmaceutical K.K. (Janssen) reported that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Tremfya(R) (guselkumab) for the treatment of patients with palmoplantar pustulosis who are not responding or are refractory to existing treatments.

November 28, 2018
·
6 min read
Drug Development

ASIT biotech has installed and qualified a pilot unit to produce clinical batches for the Phase I/II studies in house dust mite and peanut allergies expected to start in H2 2019

The active pharmaceutical ingredients (API) will be produced according to GMP requirements in a clean room rented from Accessia Pharma, a provider of high-quality pharmaceutical infrastructures

November 28, 2018
·
3 min read
Genetown

Rheostat Therapeutics Announces $23 Million Series A Financing; To Develop Potential Treatments for Neurodegenerative Diseases

Rheostat Therapeutics today announced the close of a Series A financing round totaling $23 million.

November 28, 2018
·
5 min read
Looking for ways to measure tumour aggression

Tests show an association between how aggressive a tumour is and the levels of sugar and inflammatory proteins in the blood.

November 28, 2018
·
2 min read
Business

Fusion Antibodies plc Interim Report for the six months ended 30 September 2018

Fusion Antibodies plc announces its unaudited interim results for the six months ended 30 September 2018.

November 28, 2018
·
1 min read
Drug Development

ADC Therapeutics Announces First Patients Dosed in Phase I/II Clinical Trial of ADCT-602 in Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Trial of CD22-targeting antibody drug conjugate being led by The University of Texas MD Anderson Cancer Center

November 28, 2018
·
3 min read